Schipper D et al
Experimental Results: Cartilage morphology: severe wear, erosion, and fibrosis of cartilage in the control group
Mounjaro, Zepbound, and the GLP-1-only authorized products contain different active ingredients (tirzepatide, semaglutide), not retatrutide
The pathway represents one of the more thoroughly characterized molecular mechanisms in BPC-157's published research record
Many drugs look promising in cells, mice, or tissue samples but fail in later stages because: The treatment doesnt work well enough in humans It causes side effects at real doses The effect fades over time The human joint environment is much more complex than the lab So while we are hopeful, there is a long road ahead before this approach could become a real treatment
Not every patient is a candidate, and not every peptide is appropriate for every patient